ライフサイエンスコーパス: clear cell sarcoma

1 epigenetic and 3D connectivity landscape of Clear Cell Sarcoma, an aggressive cancer driven by the E

2 and EWS/FLI1 fusion proteins associated with Clear Cell Sarcoma and Ewing's Sarcoma, respectively, we

3 otein in maintaining tumor cell viability of Clear Cell sarcoma and indicate that intracellular antib

4 a, salivary-duct cancer, ovarian cancer, and clear-cell sarcoma and among patients with colorectal ca

5 al sarcomas, round-cell/myxoid liposarcomas, clear-cell sarcomas and gastrointestinal stromal tumors

6 NSC13778 inhibited the growth of xenografted clear cell sarcoma, and no toxicity was observed.

7 chromosomal translocation t(12;22) found in Clear Cell sarcoma (CCS) fuses the genes for Ewing's sar

8 Clear cell sarcoma (CCS) is a deadly malignancy affectin

9 Clear cell sarcoma (CCS) of tendons and aponeuroses is a

10 Clear cell sarcoma (CCS), a childhood tumor of the tendo

11 Synovial sarcoma (SS), clear cell sarcoma (CCS), and desmoplastic small round c

12 81 inhibited the growth of a patient-derived clear cell sarcoma cell line whose oncogenic potential i

13 ions in primary melanocytes and melanoma and clear cell sarcoma cells through hypoxia inducible facto

14 Renal-cell carcinoma, clear-cell sarcoma, (congenital) mesoblastic nephroma, r

15 in children, including renal-cell carcinoma, clear-cell sarcoma, (congenital) mesoblastic nephroma, r

16 rous histiocytoma (AFH) and gastrointestinal clear cell sarcoma (GI-CCS), although both fusions lead

17 elective oncogene implicated in melanoma and clear-cell sarcoma (i.e., melanoma of soft parts).

18 of chemotherapy (including doxorubicin) for clear cell sarcoma improves recurrence-free survival.

19 Clear cell sarcoma of soft tissue (CCSST) is a rare sarc

20 or stages III to IV/FH WT or stages I to IV/clear cell sarcoma of the kidney (high-risk [HR] group)

21 combination chemotherapy for LR or HR WT or clear cell sarcoma of the kidney have equivalent 2-year

22 osis of rare cancers, including Wilms tumor, Clear Cell Sarcoma of the Kidney, Neuroblastoma, Osteosa

23 terminus of BCOR in 23 of 27 (85%) pediatric clear cell sarcomas of the kidney (CCSK) from two indepe

24 ), stages III to IV FH WT, or stages I to IV clear-cell sarcoma of the kidney (high-risk[HR]) were ra

25 heterogeneous group of tumours that includes clear-cell sarcoma of the kidney, congenital mesoblastic

26 al translocation associated with soft tissue clear cell sarcoma results in a chimeric protein EWS-ATF

27 ignant melanoma of soft parts or soft tissue clear cell sarcoma which shares t(12;22) chromosome tran